NCT02583399View on ClinicalTrials.gov

Safety and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 8, 2017

Primary Completion Date

July 2, 2019

Study Completion Date

July 2, 2019

Conditions
PainFever
Interventions
DRUG

Ibuprofen

Ibuprofen, 10 mg/kg

Trial Locations (4)

39216

University of Mississippi Medical Center, Jackson

40202

Kosair Charaties Pediatric Research Unit, Louisville

75235

Children's Medical Center Dallas, Dallas

77030

Baylor College of Medicine/Texas Children's Hospital, Houston

Sponsors
All Listed Sponsors
lead

Cumberland Pharmaceuticals

INDUSTRY